Guided Therapeutics (GTHP) Shares Outstanding (2010 - 2025)

Guided Therapeutics has disclosed Shares Outstanding across 16 years of filings, most recently posting $86.2 million for Q4 2025.

• Shares Outstanding for Q4 2025 came in at $86.2 million, up 32.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $86.2 million (up 32.28% YoY), and the FY2025 annual result was $86.2 million, up 32.28% from the prior year.
• Shares Outstanding came in at $86.2 million for Q4 2025 at Guided Therapeutics, up from $83.6 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $86.2 million in Q4 2025 to a low of $1000.0 in Q1 2021.
• The 5-year median for Shares Outstanding is $24.9 million (2022), against an average of $31.0 million.
• Across the five-year window, Shares Outstanding jumped 2758200.0% in 2022 and sank 100.0% in 2023, its largest moves.
• Guided Therapeutics' Shares Outstanding stood at $2000.0 in 2021, then jumped by 2429685.75% to $48.6 million in 2022, then advanced by 11.34% to $54.1 million in 2023, then increased by 20.38% to $65.1 million in 2024, then soared by 32.28% to $86.2 million in 2025.
• The last three Shares Outstanding figures came in at $86.2 million (Q4 2025), $83.6 million (Q3 2025), and $1.0 (Q2 2025), per Business Quant data.